Equities research analysts expect Apyx Medical Corp (NASDAQ:APYX) to post ($0.16) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Apyx Medical’s earnings, with estimates ranging from ($0.19) to ($0.13). Apyx Medical reported earnings per share of ($0.10) in the same quarter last year, which would indicate a negative year-over-year growth rate of 60%. The firm is expected to report its next quarterly earnings results on Wednesday, March 11th.

On average, analysts expect that Apyx Medical will report full year earnings of ($0.59) per share for the current year. For the next financial year, analysts anticipate that the company will post earnings of ($0.67) per share, with EPS estimates ranging from ($0.78) to ($0.55). Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow Apyx Medical.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Monday, November 11th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05. Apyx Medical had a negative net margin of 66.77% and a negative return on equity of 20.25%. The company had revenue of $7.58 million during the quarter, compared to analysts’ expectations of $6.78 million. The business’s quarterly revenue was up 106.3% on a year-over-year basis.

Several equities research analysts recently issued reports on APYX shares. ValuEngine raised Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 15th. Zacks Investment Research downgraded Apyx Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, Piper Jaffray Companies boosted their price objective on Apyx Medical to $10.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $8.94.

NASDAQ:APYX traded down $0.11 during trading hours on Monday, hitting $8.17. The stock had a trading volume of 947 shares, compared to its average volume of 80,240. The company has a 50 day simple moving average of $8.09 and a two-hundred day simple moving average of $7.26. The firm has a market capitalization of $280.52 million, a price-to-earnings ratio of -15.72 and a beta of 0.15. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.73 and a quick ratio of 7.93. Apyx Medical has a one year low of $3.55 and a one year high of $8.89.

Institutional investors have recently bought and sold shares of the company. Calamos Advisors LLC bought a new stake in shares of Apyx Medical during the 4th quarter worth $1,164,000. Astoria Strategic Wealth Inc. purchased a new position in shares of Apyx Medical in the 4th quarter worth about $86,000. Metropolitan Life Insurance Co NY purchased a new position in shares of Apyx Medical in the 3rd quarter worth about $87,000. State Street Corp increased its position in shares of Apyx Medical by 34.2% during the 3rd quarter. State Street Corp now owns 557,677 shares of the company’s stock valued at $3,775,000 after purchasing an additional 142,098 shares during the last quarter. Finally, Frisch Financial Group Inc. increased its position in shares of Apyx Medical by 31.7% during the 3rd quarter. Frisch Financial Group Inc. now owns 17,658 shares of the company’s stock valued at $120,000 after purchasing an additional 4,248 shares during the last quarter. Hedge funds and other institutional investors own 52.45% of the company’s stock.

Apyx Medical Company Profile

Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.

Featured Story: What is required to own or exchange cryptocurrency?

Get a free copy of the Zacks research report on Apyx Medical (APYX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.